title: Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model.
abstract: Taxol is a promising agent for use in ovarian cancer and other malignancies. One problem associated with taxol is its low aqueous solubility, requiring Cremophor EL (polyethoxylated castor oil) and ethanol as excipients (Diluent 12); these agents cause serious adverse effects. Liposomes containing taxol and phospholipid (in a 1:33 mole ratio, respectively) were prepared from phosphatidylglycerol and phosphatidylcholine in a 1:9 mole ratio. Antitumor effect was evaluated against Colon-26, a taxol-resistant murine tumor. Given as 1, 4, or 9 injections, free taxol given i.v. in Diluent 12 was ineffective at delaying tumor growth at doses < or = 30 mg/kg per injection (the maximum tolerated dose). In contrast, taxol-liposomes were well tolerated at doses greater than or equal to the maximum tolerated dose of free taxol and showed significant tumor growth inhibition at 10-45 mg/kg per injection.
authors.affiliation: Department of Pharmaceutics, University at Buffalo, State University of New York, Amherst 14260-1200.
authors.forename: A
authors.initials: A
authors.lastname: Sharma
authors.forename: E
authors.initials: E
authors.lastname: Mayhew
authors.forename: R M
authors.initials: RM
authors.lastname: Straubinger
mesh_terms: D000818:Animals; D004337:Drug Carriers; D004351:Drug Resistance; D004355:Drug Stability; D005260:Female; D008081:Liposomes; D051379:Mice; D008807:Mice, Inbred BALB C; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D017239:Paclitaxel / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D004337:Drug Carriers; D008081:Liposomes; D017239:Paclitaxel